Omega-3 Supplementation Lowers ApoB100 Levels In Obese Adolescents:A Controlled Intervention Study
DOI:
https://doi.org/10.12873/Palabras clave:
Omega-3, Apolipoprotein B100, Obesity, AdolescentsResumen
Background: Obesity is a risk factor associated with cardiovascular disease. Apolipoprotein B (ApoB) is the main protein in atherogenic lipoproteins and a strong predictor of cardiovascular risk. Omega-3 fatty acids have been shown to reduce plasma triglycerides and total ApoB levels in individuals with metabolic syndrome. This study aims to analyze the effect of omega-3 administration on ApoB-100 levels in adolescents with obesity.
Methods: This study was an experimental study with pre and post-test design, which was conducted by health students from February to April 2025 in Makassar. A total of 770 participants were screened, with 90 individuals meeting the inclusion criterion of a body mass index (BMI) ≥ 25 kg/m². ApoB-100 levels were measured using the Human Apolipoprotein B1 ELISA Kit, and lipid profiles were assessed using an automated clinical chemistry analyzer with enzymatic colorimetric methods. 37 participants completed all procedures divided into two groups: the control group (n=20), received nutritional counseling, and the intervention group (n=17) received 1200 mg omega-3 supplements daily for four weeks.
Results: The average age was 18.59 ± 0.62 years in the intervention group and 18.30 ± 0.57 years in the control group. In the intervention group, ApoB-100 levels significantly decreased from 1768.23 ± 335.18 to 1410.20 ± 191.03 mg/dL (p < 0.001). The control group showed an increase from 1582.29 ± 426.95 to 1760.29 ± 507.65 mg/dL (p = 0.156).
Conclusion: This study showed Omega-3 supplementation significantly reduced ApoB-100 levels in obese adolescents, suggesting its potential role in reducing cardiovascular risk.
Referencias
1. Gaskin CJ, Cooper K, Stephens LD, Peeters A, Salmon J, Porter J. Clinical practice guidelines for the management of overweight and obesity published internationally: A scoping review. Obes Rev [Internet]. 2024;25(5):1–15. Available from: https://doi.org/10.1111/obr.13700
2. Amusat S. Exploring the Impact of Gender and BMI on Apolipoprotein B in Adult Subjects. J Clin Lipidol [Internet]. 2024;18(4):518–9. Available from: https://doi.org/10.1016/j.jacl.2024.04.048
3. Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia Tahun 2023 [Internet]. Vol. 11, Kementerian Kesehatan Republik Indonesia. Jakarta: Kementerian Kesehatan RI; 2024. 1–14 p. Available from: http://scioteca.caf.com/bitstream/handle/123456789/1091/RED2017-Eng-8ene.pdf?sequence=12&isAllowed=y%0Ahttp://dx.doi.org/10.1016/j.regsciurbeco.2008.06.005%0Ahttps://www.researchgate.net/publication/305320484_SISTEM_PEMBETUNGAN_TERPUSAT_STRATEGI_MELESTARI
4. Taslim NA, Handayani ND, Arruan W, Aminuddin, Bukhari A, Faradillah A, et al. Dietary Patterns and Ultra-Processed Foods Consumption in Modern and Traditional Populations in South Sulawesi: An Analysis of Nutritional Status and Body Composition. Nutr Clin y Diet Hosp [Internet]. 2023;43(1):90–8. Available from: https://doi.org/10.12873/431handayani
5. Arruan W, Bukhari A, Handayani ND, Taslim NA, Faradilah A, Aminuddin. The relationship of physical activity with nutritional status and body composition in traditional and modern populations in South Sulawesi, Indonesia. Nutr Clin y Diet Hosp [Internet]. 2024;44(3):204–11. Available from: https://doi.org/10.12873/443arruan
6. Faradilah A, Bukhari A, Aminuddin A, Syauki AY. The role of obesity in altering the effects of short chain fatty acids (SCFA) on metabolic hormone regulation: A systematic review and meta-analysis. Clin Nutr Open Sci [Internet]. 2025;60:181–99. Available from: https://doi.org/10.1016/j.nutos.2025.01.011
7. Radyaputri A. The Relationship of Apolipoprotein B and Major Adverse Cardiovascular Events (MACE) in Patients with Coronary Heart Disease as a Prognostic Factor: A Literature Review. Scr SCORE Sci Med J. 2024;5(2):165–70.
8. Dorobanţu M, Halațiu VB, Gheorghe‐Fronea O, Bala CG, Moldovan H, Irinel-Parepa R, et al. The Association Between Apolipoprotein B, Cardiovascular Risk Factors and Subclinical Atherosclerosis—Findings From the SEPHAR National Registry on Hypertension in Romania. Int J Mol Sci. 2023;24(3):2813.
9. Hayat Y, Rasyid H, As’Ad S, Taslim NA, Syauki Y, Bukhari A. The Nusantara Diet of Makassar on the ratio of triglyceride to HDL on the risk of cardiovascular disease in individuals with the risk of metabolic syndrome. Nutr Clin y Diet Hosp [Internet]. 2024;44(4):60–4. Available from: https://doi.org/10.12873/444hayat
10. Huang M, Zheng J, Chen L, You S, Huang H. Role of apolipoproteins in the pathogenesis of obesity. Clin Chim Acta [Internet]. 2023;1(5):545. Available from: https://doi.org/10.1016/j.cca.2023.117359
11. Jun H, Ko J, Jung H, Yoon C, Kim T, Kwon M, et al. Effect of Omega-3 Fatty Acids on Low Density Lipoprotein Subfraction, Adiponectin and Apolipoprotein B in Type 2 Diabetic Patients. J Clin Endocrinol Metab [Internet]. 2011;26(3):218–24. Available from: https://doi.org/10.3803/EnM.2011.26.3.218
12. Ferchaud-Roucher V, Zair Y, Aguesse A, Krempf M, Ouguerram K. Omega 3 improves both apoB100-containing lipoprotein turnover and their sphingolipid profile in hypertriglyceridemia. J Clin Endocrinol Metab [Internet]. 2020;105(10):3152–64. Available from: https://doi.org/10.1210/clinem/dgaa459
13. Devaraj S, Semaan JR, Jialal I. Biochemistry, Apolipoprotein B. StatPearls [Internet] Treasure Isl StatPearls Publ. 2023;
14. Galimberti F, Casula M, Olmastroni E. Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment. Pharmacol Res [Internet]. 2023;195(6):106873. Available from: https://doi.org/10.1016/j.phrs.2023.106873
15. Gunawan AD, Bardosono S, Mudjihartini N. Association between apolipoprotein B and dietary fibers. World Nutr J [Internet]. 2021;4(2):73–83. Available from: https://doi.org/10.25220/wnj.v04.i2.0010
16. Wang T, Zhang X, Zhou N, Shen Y, Li B, Chen BE, et al. Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose–Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc [Internet]. 2023;12(11). Available from: https://doi.org/10.1161/JAHA.123.029512
17. National Institutes of Health N. Omega-3 fatty acids Fact sheet for consumers. Natl Institutes Heal [Internet]. 2018;1–3. Available from: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/
18. Chan DC, Watts GF, Mori TA, Barrett PHR, Redgrave TG, Beilin LJ. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr [Internet]. 2003;77(2):300–7. Available from: https://doi.org/10.1093/ajcn/77.2.300
19. Caviglia JM, Gayet C, Ota T, Hernandez-Ono A, Conlon DM, Jiang H, et al. Different fatty acids inhibit apoB100 secretion by different pathways: Unique roles for ER stress, ceramide, and autophagy. J Lipid Res [Internet]. 2011;52(9):1636–51. Available from: https://doi.org/10.1194/jlr.M016931
20. Shidfar F, Keshavarz A, Hosseyni S, Ameri A, Yarahmadi S. Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients. East Mediterr Heal J [Internet]. 2008;14(2):305–13. Available from: https://pubmed.ncbi.nlm.nih.gov/18561722/
21. Chang JPC, Tseng PT, Zeng BS, Chang CH, Su H, Chou PH, et al. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr [Internet]. 2023;14(6):1326–36. Available from: https://doi.org/10.1016/j.advnut.2023.08.003
22. Ouguerram K, Maugeais C, Gardette J, Magot T, Krempf M. Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects. Br J Nutr [Internet]. 2006;96(01):100. Available from: https://doi.org/10.1079/bjn20061806
23. Manapurath RM, Hadaye R, Gadapani B. Normal Weight Obesity: Role of apoB and Insulin Sensitivity in Predicting Future Cardiovascular Risk. Int J Prev Med [Internet]. 2022;13:1–4. Available from: https://doi.org/10.4103/ijpvm.IJPVM
24. Kim HJ, Lee HJ, Choi JS, Han J, Kim JY, Na HK, et al. An apolipoprotein B100 mimotope prevents obesity in mice. Clin Sci [Internet]. 2016;130(2):105–16. Available from: https://doi.org/10.1042/CS20150423
25. Ogbodo EC, Onah CE, Meludu SC, Ogbodo MC, Ezeugwunne IP, Ehiage FA, et al. Anthropometric Indices, Blood Pressure and Some Apolipoproteins in older Adults in Nnewi, Southeast Nigeria. African J Biomed Res [Internet]. 2024;27(1):39–47. Available from: https://doi.org/10.4314/ajbr.v27i1.5
Descargas
Publicado
Número
Sección
Categorías
Licencia
Derechos de autor 2025 Nutrición Clínica y Dietética Hospitalaria
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los lectores pueden utilizar los textos publicados de acuerdo con la definición BOAI (Budapest Open Access Initiative)
